China Life Private Equity Investment is a principal investment firm that focus on investments in infrastructure, construction, culture and media.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
China Life Private Equity Investment is a principal investment firm that focus on investments in infrastructure, construction, culture and media.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2020 | OPM Biosciences | Corporate Round | 14.4M |
6/2022 | Hanbang Technology | Series C | 0 |
7/2022 | MAXVAX | Series B | 0 |
9/2013 | Asia Bioenergy Technologies Berhad | Venture Round | 1.6M |
10/2021 | SinoTau | Series D | 0 |
6/2022 | Doma Biopharmaceutical | Series A | 0 |
8/2018 | Harbour Biomed | Series B | 0 |
12/2022 | MAXVAX | Series B | 43M |
5/2021 | GeneQuantum Healthcare | Series C | - |
12/2022 | Fushoukang | Series C | 14.3M |
4/2022 | METiS Therapeutics | Series B | 0 |
11/2021 | Immunochina | Series D | - |
6/2018 | Wanka Online | Series C | 0 |
7/2022 | MAXVAX | Series B | 0 |
6/2022 | Hanbang Technology | Series C | 0 |
6/2022 | Doma Biopharmaceutical | Series A | 0 |
4/2022 | METiS Therapeutics | Series B | 0 |
11/2021 | Immunochina | Series D | - |
10/2021 | SinoTau | Series D | 0 |
5/2021 | GeneQuantum Healthcare | Series C | - |
3/2020 | OPM Biosciences | Corporate Round | 0 |
8/2018 | Harbour Biomed | Series B | 0 |
6/2018 | Wanka Online | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|